{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:41Z","timestamp":1790629781141,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["280873"],"award-info":[{"award-number":["280873"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jconrel.2019.04.043","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T16:26:23Z","timestamp":1557246383000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA"],"prefix":"10.1016","volume":"304","author":[{"given":"Anna K.","family":"Blakney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-8639","authenticated-orcid":false,"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Ibarzo","family":"Yus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Aldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.04.043_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0010","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/652399","article-title":"Protective immunity to chlamydial genital infection: evidence from animal studies","volume":"201","author":"Rank","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"A mucosal vaccine against chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0020","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3389\/fimmu.2017.01652","article-title":"Protective effect of vaccine promoted neutralizing antibodies against the intracellular pathogen chlamydia trachomatis","volume":"8","author":"Olsen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0025","article-title":"Status of vaccine research and development of vaccines for chlamydia trachomatis infection","author":"Poston","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0035","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/eji.200535730","article-title":"Long-lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation","volume":"36","author":"Bachmann","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smim.2018.10.003","article-title":"Immunocorrelates of CAF family adjuvants","volume":"39","author":"Pedersen","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00898","article-title":"Induction of cytotoxic T-lymphocyte responses upon subcutaneous administration of a subunit vaccine adjuvanted with an emulsion containing the toll-like receptor 3 ligand poly(I:C)","volume":"9","author":"Schmidt","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0055","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.vaccine.2014.05.050","article-title":"Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant","volume":"32","author":"Korsholm","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.10.002","article-title":"Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal cationic adjuvant formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated resiquimod+CAF01","volume":"291","author":"Wilkinson","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0065","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s11095-017-2180-9","article-title":"Systematic investigation of the role of surfactant composition and choice of oil: design of a nanoemulsion-based adjuvant inducing concomitant humoral and CD4+ T-cell responses","volume":"34","author":"Schmidt","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2016.08.034","article-title":"The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: the immunological consequences of the biodistribution profile","volume":"239","author":"Schmidt","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0075","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2217\/nnm.14.197","article-title":"A stable nanoparticulate DDA\/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4+ T-cell response","volume":"9","author":"Karlsen","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0080","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jconrel.2012.03.016","article-title":"A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog","volume":"160","author":"Christensen","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0085","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0090","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1016\/j.vaccine.2011.07.025","article-title":"Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01","volume":"29","author":"Fomsgaard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/icb.2015.79","article-title":"A multi-subunit chlamydia vaccine inducing neutralizing antibodies and strong IFN-\u03b3+ CMI responses protects against a genital infection in minipigs","volume":"94","author":"B\u00f8je","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0105","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0120","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.05738-11","article-title":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion","volume":"86","author":"Jensen","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0130","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2010.11.021","article-title":"Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method","volume":"150","author":"Nordly","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0140","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1017\/S0031182015001250","article-title":"Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB\/c mice challenged with Leishmania (infantum) chagasi","volume":"142","author":"Leal","year":"2015","journal-title":"Parasitology"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0145","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.10.043","article-title":"CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations","volume":"390","author":"Christensen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6\u2032-dibehenate)\u2014A novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"Davidsen","year":"2005","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141209","article-title":"Intramuscular immunisation with chlamydial proteins induces chlamydia trachomatis specific ocular antibodies","volume":"10","author":"Badamchi-Zadeh","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084707","article-title":"Glucopyranosyl lipid a adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen","volume":"9","author":"McKay","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2017.09.018","article-title":"Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure","volume":"266","author":"D\u00e9moulins","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0180","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.vaccine.2017.02.020","article-title":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a chlamydia muridarum respiratory challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.192581499","article-title":"Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells","volume":"99","author":"Thomas","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0190","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.2147\/IJN.S140734","article-title":"Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene","volume":"12","author":"Nouri","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2010.06.029","article-title":"Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery","volume":"397","author":"He","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0205","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/intimm\/dxu055","article-title":"Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens","volume":"26","author":"Sheppard","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0215","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/14760584.2013.811208","article-title":"The use of toll-like receptor 7\/8 agonists as vaccine adjuvants","volume":"12","author":"Vasilakos","year":"2013","journal-title":"Exp. Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2019.04.043_bb0220","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nbt1001","article-title":"Evolution of a T7 RNA polymerase variant that transcribes 2\u2032-O-methyl RNA","volume":"22","author":"Chelliserrykattil","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.04.043_bb0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1753425916651132","article-title":"Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo","volume":"22","author":"Huber","year":"2016","journal-title":"Innate Immun"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:40:05Z","timestamp":1759160405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919302469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":45,"alternative-id":["S0168365919302469"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}